<DOC>
	<DOC>NCT02656914</DOC>
	<brief_summary>The purpose of this study is to evaluate the non inferiority of the clinical efficacy of the drug associations in the treatment of flu symptoms</brief_summary>
	<brief_title>Comparison of EMS Association to Resfenol® to Treat Flu Symptoms</brief_title>
	<detailed_description>Open-label,randomized, multicenter; Maximal experiment duration: 10 days; 03 visits; Safety and efficacy evaluation</detailed_description>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine, phenylpropanolamine drug combination</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Participant within 72 hours of the onset of flu symptoms, according to Ministry of Health Protocol (2013); Signed Consent of the patient; Participant whose tutors have the capacity to understand and consent to the child's participation in the clinical study, manifested by signing TCLE Patients with any clinically significant disease that in the investigator is opinion can´t participate in the study; Patients with any laboratory finding or image finding that in the investigator is opinion can´t participate in the clinical trial; Patients with history of hypersensitivity to any of the formula compounds; Participation in clinical trial in the year prior to this study; Patients with vaccine reaction; Patients who have uncontrolled asthma however, participants in use of pulmonary corticosteroids (alone or in combination with other products) will be allowed if they are in stable dose and diagnosed with controlled asthma; Patients with gastroesophageal reflux, gastric or duodenal ulcer or other serious disease of the gastrointestinal tract; Patients with diabetes mellitus type I and II; Pregnancy or risk of pregnancy and lactating patients; Patients who were in use of drugs that can interfere with flu symptoms evaluation.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>